Targets › AG
1 program from 1 company in 2 trials: 2 Phase 2; Gastroenterology; next expected readout Aug 2027.
Open in Phaseline: the race on AG, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| The University of Hong Kong | Silver diamine fluoride gel Silver and fluoride-based antimicrobial and remineralization agent for caries arrest | AG | Phase 2 | Early Childhood Caries; Early Childhood Caries (ECC) | Aug 2027 |
Early Childhood Caries (1) Early Childhood Caries (ECC) (1)
small molecule (1)
The University of Hong Kong (1)
–
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.